FindTrial
Sign In

The Real Life Treating Patterns of Adjuvant Therapy in HR-Positive Postmenopausal Breast Cancer Patients in Western China

The Real Life Treating Patterns of Adjuvant Therapy in HR-Positive Postmenopausal Breast Cancer Patients in Western China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-14005520
Enrollment
Unknown
Registered
2014-11-14
Start date
2005-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

N/A:N/A

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Histologically confirmed HR+ postmenopausal breast cancer by pathological evaluation; 2. Postmenopausal woman, defined as a woman fulfilling any 1 of the following criteria (based on the NCCN definition of menopause (National Comprehensive Cancer Network 2008)): (1) Prior bilateral oophorectomy (2) Age older than 60 years; (3) Age younger than 60 years and amenorrheic for 12 or more months in the absence of chemotherapy, tamoxifen, toremifene, or ovarian suppression and follicle stimulating hormone and oestradiol in the postmenopausal range. 3. Received adjuvant therapy for early breast cancer.

Exclusion criteria

Exclusion criteria: Insufficiency of characteristics at baseline.

Design outcomes

Primary

MeasureTime frame
Disease-free survival;Overall survival;—

Countries

China

Contacts

Public ContactHong Zheng
hong_zheng11@yahoo.com+86 18980601830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026